Back
ESC2025 Premium Access

A novel strategy for reducing time between antiplatelet drug cessation and urgent CABG surgery following acute coronary syndromes

Session: Risk modification in coronary artery bypass surgery
Topic: Coronary Arteries
Speaker: Professor R. Storey (Sheffield, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
24 presentations
1 follower

5 more presentations in this session

Hybrid coronary revascularization vs. coronary artery bypass grafting in multivessel coronary artery disease

Speaker: Doctor S. Corradetti (Rome, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Long term outcomes of coronary artery bypass grafting using the pure internal thoracic artery (PITA-CABG) technique

Speaker: Mr H. Yong (Glasgow, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Chronic coronary total occlusions: does surgery hold the answer?

Speaker: Doctor A. Silva (Coimbra, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Influence of baseline Hb1Ac and antiplatelet therapy on 5-year clinical outcomes after coronary artery bypass grafting.

Speaker: Doctor Q. Liu (Shanghai, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

A head-to-head comparison of physiology versus angiography-guided coronary artery bypass grafting

Speaker: Doctor A. Silva (Coimbra, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Risk modification in coronary artery bypass surgery

Speakers: Professor R. Storey, Doctor S. Corradetti, Mr H. Yong, Doctor A. Silva, Doctor Q. Liu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources